Description
Phase
Phase 1/2 - for trials that are a combination of phases 1 and 2.Inclusion and Exclusion Criteria
Please contact Anayansi Miloud to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033
- Innovative Clinical Research Institute, Whittier, California, 90603
- UCLA Medical Center, Santa Monica, California, 90404
- UCLA Medical Center, Los Angeles, California, 90095
- Sharp Clinical Oncology Research-Sharp Memorial Hospital, San Diego, California, 92123
-
Arizona
- Mayo Clinic-Scottsdale, Scottsdale, Arizona, 85259
- Mayo Clinic-Scottsdale, Scottsdale, Arizona, 85259
-
Oregon
- Providence Portland Medical Center, Portland, Oregon, 97213
-
Washington
- Swedish Cancer Institute, Seattle, Washington, 98104
- University of Washington Medical Center, Seattle, Washington, 98109
- University of Washington Medical Center, Seattle, Washington, 98109
-
Texas
- University of Texas Southwestern Medical Center, Dallas, Texas, 75390
-
Nebraska
- University of Nebraska Medical Center Eppley Cancer Center, Omaha, Nebraska, 68198
-
Minnesota
- Mayo Clinic-Rochester, Rochester, Minnesota, 55905
-
Missouri
- Washington University School of Medicine, St. Louis, Missouri, 63110
-
Tennessee
- The West Clinic, Memphis, Tennessee, 38120
- Sarah Cannon Research Institute, Nashville, Tennessee, 37203
-
Wisconsin
- University of Wisconsin-Carbone Cancer Center, Madison, Wisconsin, 53579
-
Illinois
- University of Chicago, Chicago, Illinois, 60637
- Northwestern University The Feinberg School of Medicine, Chicago, Illinois, 60611
-
Indiana
- Indiana University Melvin and and Bren Simon Cancer Center, Indianapolis, Indiana, 46202
-
Ohio
- University of Cincinnati Cancer Institute, Cincinnati, Ohio, 45267
- Oncology Hematology in Cincinnati, Cincinnati, Ohio, 45242
-
France
- Hopital Saint Antoine, Creteil Cedex, 94010
- Hopital Saint Antoine, Creteil Cedex, 94010
- CHRU de Lille, Lille cedex, 59037
- Hopital Tenon, Paris, 75020
- Centre Hospitalier de Grenoble, Grenoble, 38043